rs104886221
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_033380.3(COL4A5):c.3197G>A(p.Gly1066Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1066V) has been classified as Pathogenic.
Frequency
Consequence
NM_033380.3 missense
Scores
Clinical Significance
Conservation
Publications
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL4A5 | ENST00000328300.11 | c.3197G>A | p.Gly1066Asp | missense_variant | Exon 36 of 53 | 1 | NM_033380.3 | ENSP00000331902.7 | ||
| COL4A5 | ENST00000483338.1 | c.2021G>A | p.Gly674Asp | missense_variant | Exon 20 of 20 | 1 | ENSP00000495685.1 | |||
| COL4A5 | ENST00000361603.7 | c.3197G>A | p.Gly1066Asp | missense_variant | Exon 36 of 51 | 2 | ENSP00000354505.2 | |||
| COL4A5 | ENST00000505728.1 | c.428G>A | p.Gly143Asp | missense_variant | Exon 4 of 5 | 3 | ENSP00000424137.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
X-linked Alport syndrome Pathogenic:2
- -
- -
not provided Pathogenic:1
The variant disrupts a glycine residue in the canonical Gly-X-Y repeats of the triple helix domain, which are required for stability and structure of this protein. Therefore it is expected to severely affect the function of the protein. Found in at least one patient with expected phenotype for this gene, and not found in general population data. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at